ALKM – Alkame Fulfillment Of $1 PPE Million Sales Contract Continues Alongside Expanding Co-Packing Operations
Las Vegas, Nevada, June 16, 2021 (GLOBE NEWSWIRE) -- Alkame Holdings, Inc. (OTC Pink: ALKM), today announced the ongoing fulfillment of a $1 million of Personal Protection Equipment (PPE) sales contract with Aladyn Protection Systems, LLC.
ALKM’s PPE business continues alongside the company’s expanding co-packing operations with a backlog of new product development.
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded holding company that operates with a focus in distinct sectors: health and wellness, technology, manufacturing, and distribution. The Company's wholly owned subsidiaries manufacture and distribute products with an emphasis on utilizing an enhanced water technology with several unique properties. The water technology is supported by four independent human clinical studies. There are a multitude of product applications we currently, or have capability to, utilize with our technology to produce and/or add value to, including but not limited to, consumer beverages, CBD/hemp products, pet products, horticulture, agriculture and aquaculture applications, and hand sanitizers.
For more information, visit www.alkameholdingsinc.com.
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
